@FierceBiotech: ICYMI: Novo's liraglutide works in diabetes and obesity. How about NASH? More | Follow @FierceBiotech
@JohnCFierce: Got a few personal notes and saw at least 1 Twitter campaign linked to our "Influentials' list. Check out the report. Feature | Follow @JohnCFierce
> The European Medicines Agency's Committee for Medicinal Products for Human Use is slated to weigh in on Amgen's ($AMGN) cholesterol-lowering antibody evolocumab this week. Agenda
> Vaccine developer Medicago is spending $245 million to construct a new manufacturing facility in its native Quebec. News
> DNAtrix has teamed up with Alcyone Lifesciences, planning to use the company's drug delivery technology as it develops a treatment for brain cancer. More
Medical Device News
@FierceMedDev: UPDATED w/ interview: Apollo's minimally invasive intragastric weight-loss balloon shows promise in clinical trial. Story | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Advice for med tech entrepreneurs: Identify your customer and consider stakeholders' incentives carefully. Editor's corner | Follow @VarunSaxena2
@EmilyWFierce: $ILMN filed a patent infringement suit against Ariosa/$RHHBY over prenatal testing tech. Release | Follow @EmilyWFierce
> Silk Road scores FDA approval for less invasive stent system. Story
> NEA startup ClarVista gets $14.5M to gain CE mark for intraocular lens. Article
Pharma News
@FiercePharma: J&J nears $7.5M deal in Risperdal case that could have cost $1.2B. Report | Follow @FiercePharma
@EricPFierce: FDA blesses Baxter saline plant in Spain for shipments to U.S. of 0.9% sodium chloride. FiercePharmaManufacturing story | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Perrigo will talk tie-up if the price is right, CEO says--but Mylan has a ways to go. Report | Follow @CarlyHFierce
> Can Baxalta deliver on its big growth promises? Baxter says yes. More
> Merck KGaA stumbles in Q1 as MS injectable Rebif falls to oral rivals. Report
> Lechleiter takes up Big Pharma's torch to 'debunk' negative myths. Item
Drug Delivery News
> 'Nanosponges' held in place with a hydrogel absorb toxins in MRSA infections. Story
> Study finds testosterone gels and patches safer than injections. More
> Endo to buy Par Pharma for $8B to bulk up in injectables. Item
> Celyad, formerly Cardio3, files for U.S. IPO worth up to $115 million. Article
> FDA approves pediatric version of Treximet to treat migraines. Report
Pharma Manufacturing News
> Pharmaniaga project in Saudi Arabia stalls but others move forward. More
> Janssen gets Rutgers' help in move to continuous manufacturing. Article
> FDA blesses Baxter saline plant in Spain to produce for U.S. More
> J&J donates $6M to Rutgers, which is helping Janssen move to continuous manufacturing. Story
> AstraZeneca says Sweden getting its new $285M biologics plant. Report
Pharma Asia News
> Wockhardt faces long haul on FDA travails, Business Today says. Story
> India's Zydus Cadila has 10 vaccines in development, set to launch next year. More
> India drug IP laws in spotlight again in local Fresenius Kabi-Pfizer case. Article
> Taiwan recalls batches of injectable sodium chloride made by Y.F. Chemical. Report
> Thailand faces pushback from private hospitals on cost claims. Item